Mednax Inc (MD)
Financial leverage ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 2,219,810 | 2,347,890 | 2,722,550 | 3,347,950 | 4,145,900 |
| Total stockholders’ equity | US$ in thousands | 849,061 | 891,632 | 896,487 | 747,485 | 1,499,000 |
| Financial leverage ratio | 2.61 | 2.63 | 3.04 | 4.48 | 2.77 |
December 31, 2023 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $2,219,810K ÷ $849,061K
= 2.61
The financial leverage ratio of Pediatrix Medical Group Inc has shown fluctuating trends over the past five years. In 2023 and 2022, the ratio decreased slightly to 2.61 and 2.63, respectively, indicating a slight improvement in the company's ability to meet its financial obligations using debt. However, in 2021, the ratio significantly increased to 3.04, which suggests a higher level of financial leverage and dependency on debt to finance its operations.
The most notable increase in the financial leverage ratio occurred in 2020 when it surged to 4.48. This substantial increase indicates a significant rise in the company's debt relative to its equity, signaling potential financial risk and vulnerability to market fluctuations or economic downturns.
In 2019, the ratio was comparatively lower at 2.77, reflecting a moderate level of financial leverage. Overall, the trend in the financial leverage ratio for Pediatrix Medical Group Inc shows variability in the company's capital structure and financial risk management over the five-year period. Investors and stakeholders may want to further investigate the reasons behind these fluctuations and assess the company's long-term financial health and stability.
Peer comparison
Dec 31, 2023